“…Positron emission tomography is presently experiencing a quantitative change in diagnosis paradigm (Alavi et al, 2021;Djekidel et al, 2022;Królicki and Kunikowska, 2021;Surti et al, 2020;Vanderberghe et al, 2020). With the advent of total-body PET systems (Badawi et al, 2019;Hu et al, 2022;Karp et al, 2020;Niedzwiecki et al, 2017;Prenosil et al, 2022), covering the whole human body (with the detector length of about 2 m), the simultaneous imaging of the metabolism rate of all organs and tissues in the body becomes possible. This opens possibilities for studies (in physiology, biochemistry and pharmacology) of the kinetics of administered pharmaceuticals in the whole body, and in determining pharmaceuticals' uptake correlations in close and distance organs (Badawi et al, 2019;Zhang et al, 2020).…”